Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor κB–binding site: Evidence that cytoplasmic location of X protein is essential for gene transactivation
Pedro Majano
Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, Madrid, Spain
Search for more papers by this authorEnrique Lara-Pezzi
Liver and Molecular Biology Units, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Search for more papers by this authorManuel López-Cabrera
Liver and Molecular Biology Units, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Search for more papers by this authorArantxa Apolinario
Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, Madrid, Spain
Search for more papers by this authorRicardo Moreno-Otero
Liver and Molecular Biology Units, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Search for more papers by this authorCorresponding Author
Carmelo García-Monzón
Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, Madrid, Spain
Carmelo García-Monzón, M.D., Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, O'Donnell 59, 28009-Madrid, Spain. fax: (34) 91-409 6185===Search for more papers by this authorPedro Majano
Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, Madrid, Spain
Search for more papers by this authorEnrique Lara-Pezzi
Liver and Molecular Biology Units, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Search for more papers by this authorManuel López-Cabrera
Liver and Molecular Biology Units, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Search for more papers by this authorArantxa Apolinario
Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, Madrid, Spain
Search for more papers by this authorRicardo Moreno-Otero
Liver and Molecular Biology Units, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain.
Search for more papers by this authorCorresponding Author
Carmelo García-Monzón
Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, Madrid, Spain
Carmelo García-Monzón, M.D., Hepatology Unit, Hospital Universitario Santa Cristina, Universidad Autónoma de Madrid, O'Donnell 59, 28009-Madrid, Spain. fax: (34) 91-409 6185===Search for more papers by this authorAbstract
Nitric oxide appears to play a central role in the pathogenesis of many inflammatory disorders. We have previously shown that there is an enhanced intrahepatic expression of the inducible nitric oxide synthase (iNOS) gene during chronic hepatitis B virus infection, and that viral X protein (HBx) transcriptionally activates this cellular gene, but the molecular basis for this activation remains to be defined. We aimed to explore the involvement of different cis-acting elements of the human iNOS promoter in the HBx-mediated up-regulation as well as the effect of the intracellular distribution of the HBx on its transacting function. Cotransfection of human hepatocyte-derived cells with wild-type or mutated iNOS promoter and with an HBx expression vector showed that functional inactivation of the proximal nuclear factor κB (NF-κB)–binding site of the iNOS promoter markedly reduced the HBx-mediated transcriptional activity. Mobility shift assays showed increased DNA-protein complexes comprising mainly the p50 and p65 members of NF-κB family in the nuclear extracts from HBx-transfected cells. Transient transfection experiments with HBx-expressing plasmids containing distinct cellular localization sequences showed that cytoplasmic location of this viral protein activated the iNOS promoter but when HBx was targeted to the nucleus, the HBx-induced luciferase activity was almost completely abrogated. In conclusion, cytoplasmic location of HBx protein is essential for the transcriptional activation of the iNOS gene through the nuclear translocation of p50-p65 heterodimers.
References
- 1 Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–2012.MEDLINE
- 2 Lyons CR. The role of nitric oxide in inflammation. Adv Immunol 1995; 1995;60: 323–371.MEDLINE
- 3 Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1992; 89: 3030–3034.MEDLINE
- 4 Majano PL, García-Monzón C, López-Cabrera M, Lara-Pezzi E, Fernández-Ruiz E, García-Iglesias C, Borque MJ, et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest 1998; 101: 1343–1352.MEDLINE
- 5 García-Monzón C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol 2000; 32: 331–338.MEDLINE
- 6 Marks-Konczalik J, Chu SC, Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor-κB-binding sites. J Biol Chem 1998; 273: 22201–22208.MEDLINE
- 7 Amaro MJ, Bartolomé J, Carreño V. Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter. Hepatology 1999; 29: 915–923.MEDLINE
- 8 Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489–495.MEDLINE
- 9 Chen HS, Kaneko S, Girones R, Anderson RW, Hornbockle WE, Tennant BC, Cote PJ, et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993; 67: 1218–1226.MEDLINE
- 10 Koike K. Hepatits B virus HBx gene and hepatocarcinogenesis. Intervirology 1995; 38: 134–142.MEDLINE
- 11 Feitelson MA, Duan LX. Hepatits B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997; 150: 1141–1157.MEDLINE
- 12 Cheong JH, Yi MK, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 1995; 14: 143–150.MEDLINE
- 13 Qadri Y, Maguire HF, Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A 1995; 92: 1003–1007.MEDLINE
- 14 Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991; 252: 842–844.MEDLINE
- 15 Benn J, Schneider RJ. Hepatitis B virus HBx activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signalling cascade. Proc Natl Acad Sci U S A 1994; 91: 10350–10354.MEDLINE
- 16 Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995; 14: 4747–4757.MEDLINE
- 17 Baldwin AS, Jr. The transcription factor NF-κB and human disease. J Clin Invest 2001; 107: 3–6.MEDLINE
- 18 Baldwin AS, Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–683.MEDLINE
- 19 Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001; 107: 7–11.MEDLINE
- 20 Lara-Pezzi E, Majano PL, Yánez-Mo M, Gómez-Gonzalo M, Carretero M, Moreno-Otero R, Sánchez-Madrid F, López Cabrera M. Effect of the hepatitis B virus HBx on protein-mediated adhesion to and migration on extracellular matrix. J Hepatol 2001; 34: 409–415.MEDLINE
- 21 Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G. Hepatitis B virus pX activates NF-κB dependent transcription through a Raf-independent pathway. J Virol 1996; 70: 641–646.MEDLINE
- 22 Rincón M, Flavell RA. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J 1994; 13: 4370–4381.MEDLINE
- 23 García-Monzón C, García-Buey L, García-Sánchez A, Pajares JM, Moreno-Otero R. Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon-alpha 2b. Gastroenterology 1993; 105: 462–469.MEDLINE
- 24 González-Amaro R, García-Monzón C, García-Buey L, Moreno-Otero R, Alonso JL, Yagüe E, Pivel JP, et al. Induction of tumor necrosis α production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994; 179: 841–848.MEDLINE
- 25 Yokoo T, Kitamura M. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am J Physiol 1996; 270: F123–F130.MEDLINE
- 26 Han ZN, Boyje DL, Manning AM, Firestein GS. AP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 1998; 28: 197–208.MEDLINE
- 27 Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264–274.MEDLINE
- 28 Moreno-Otero R, García.Buey L, Mateos FG, García-Monzón C. Pathogenesis of chronic viral hepatitis: Lessons from immunohistochemistry. Viral Hepatitis Rev 1996; 2: 61–79.
- 29 Lara-Pezzi E, Majano PL, Gómez-Gonzalo M, García-Monzón C, Moreno-Otero R, Levrero M, López-Cabrera M. The hepatitis B virus X protein up-regulates tumor necrosis factor α expression in hepatocytes. Hepatology 1998; 28: 1013–1021.MEDLINE
- 30 Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A, Balsano C, Levrero M. Ras- and raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 1994; 9: 2837–2843.MEDLINE
- 31 Wang WL, London WT, Lega L, Feitelson MA. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 1991; 14: 29–37.MEDLINE
- 32 Su Q, Shroder C, Hofmann W, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998; 27: 1109–1120.MEDLINE
- 33 Murakami S. Hepatitis B virus X protein: Structure, function and biology. Intervirology 1999; 42: 81–99.MEDLINE
- 34 Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K. High-level expression of hepatitis B virus HBx gene and hepatocellular carcinogenesis in transgenic mice. Hepatology 1994; 19: 810–819.MEDLINE
- 35 Moreno-Otero R, García-Monzón C, García-Sánchez A, García-Buey L, Pajares JM, Di Bisceglie A. Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBeAg-positive asymptomatic carriers. Am J Gastroenterol 1991; 86: 1538–1542.
- 36 Guidotti LG, McClary H, Loudis JM, Chisari FV. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 2000; 191: 1247–1252.MEDLINE
- 37 Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036–2044.MEDLINE
- 38 Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001–1003.MEDLINE
- 39 Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990; 87: 10043–10047.MEDLINE
- 40 Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81: 987–991.MEDLINE
- 41 McClary H, Koch R, Chisari FV, Guidotti LG. Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice. J Exp Med 2000; 192: 289–294.MEDLINE
- 42 García-Monzón C, Sánchez-Madrid F, García-Buey L, García-Arroyo A, García-Sánchez A, Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 1995; 108: 231–241.MEDLINE
- 43 Calmels S, Hainaut P, Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 1997; 57: 3365–3369.MEDLINE
- 44 Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A 1997; 94: 14707–14712.MEDLINE
- 45 Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129: 142–148.MEDLINE
- 46 Liu P, Yin K, Nagele R, Wong PYK. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil infiltration in hepatic ischemia-reperfusion. J Pharmacol Exp Ther 1998; 284: 1139–1146.MEDLINE
- 47 Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W. Local administration of antisense phosphorotionate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 1996; 2: 998–1004.MEDLINE
- 48 Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107: 135–142.MEDLINE